Recognizing IPED Use in Clinical Practice

27 Apr 2022

Recognizing IPED Use in Clinical Practice / Samuell Iff, Roman Gähwiler, Ingo Butzke, Boris B. Quednow, Malte Christian Claussen

  • Praxis 111 (2022) 6 (April), p. e333-e337
  • PMID: 35473328
  • DOI: 10.1024/1661-8157/a003874


Abstract

The non-medical use of image- and performance-enhancing drugs (IPEDs) is widespread in the fitness and bodybuilding scene. The reasons for IPED use are often hedonistic in nature and they are used in so-called "cycles" over several weeks. The most common side effects are: testicular atrophy, acne, hypersexuality, hypertension, gynecomastia, lipid metabolism disorders, mood swings, hair loss, and policythemia. Common consequences following IPED use are: decreased libido, oligo- or azoospermia, and erectile dysfunction. To reduce undesirable side effects and consequences, IPED users often take medications for self-treatment; occasionally IPED users also mention such medications and ask for them in the general medical practice.

NADO Flanders Annual Report 2021 (Belgium)

27 Apr 2022

Jaarverslag 2021 NADO Vlaanderen : zeg neen tegen doping / NADO Flanders. - Brussels : Flemish Government, 2022

CCES 2022 CCES vs Cody Sheppard

21 Apr 2022

In March 2022 the Canadian Centre for Ethics in Sport (CCES) has reported an anti-doping rule violation against the powerlifter Cody Sheppard after his sample tested positive for the prohibited substance GW501516.

After notification the Athlete gave a prompt admission, waived his right for a hearing, accepted a provisional suspension and the sanction proposed by CCES.

Because the Athlete signed and submitted the Early Admission and Acceptance Form the Athlete received a 1 year reduction from CCES.

Therefore CCES decides on 21 April 2022 to impose a 3 year period of ineligibility on the Athlete, starting on the date of the provisional suspension, i.e. on 4 April 2022.

World Athletics 2022 WA vs Mathew Kipkoeck Kisorio

15 Apr 2022

In March 2022 the Athletics Integrity Unit (AIU) of World Athletics has reported an an anti-doping rule violation against the Kenyan Athlete Mathew Kipkoeck Kisorio for his 3 Whereabouts Filing Failures and 1 Missed Test within a 12 month period, beginning in February 2021.

In this matter the Athlete failed to respond or provided insufficient explanations, nor requested an administrative review. Previously the Ahtlete had been sanctioned for 2 years in July 2012 for the presence of a prohibited substance.

After notification a provisional suspension was ordered while the Athlete failed to respond to the communications of the AIU. Because the Athlete failed to respond to the charge within the set deadline the AIU deems that the Athlete has admitted the anti-doping rule violation, waived his right for a hearing and accepted the consequences thereupon.

Therefore the AIU decides on 15 April 2022 to impose a 4 year period of ineligibility on the Athlete for his second anti-doping rule violation, starting on the date of the provisional suspension, i.e. 8 March 2022.

World Athletichs 2022 WA vs Justus Kimutai

15 Apr 2022

In March 2022 the Athletics Integrity Unit (AIU) of World Athletics has reported an an anti-doping rule violation against the Kenyan Athlete Justus Kimutai for his Whereabouts Filing Failure and 4 Missed Tests within a 12 month period, beginning in December 2020.

After notification a provisional suspension was ordered while the Athlete failed to respond to the communications of the AIU. Because the Athlete failed to respond to the charge within the set deadline the AIU deems that the Athlete has admitted the anti-doping rule violation, waived his right for a hearing and accepted the consequences thereupon.

Therefore the AIU decides on 15 April 2022 to impose a 2 year period of ineligibility on the Athlete starting on the date of the provisional suspension, i.e. 4 March 2022.

SADA Annual Report 2021 (Slovakia)

11 Apr 2022

Annual Report 2021 / Slovak Anti-Doping Agency (SADA). - Bratislava : Antidopingová Agentúra Slovenskej Republiky (ADA SR), 2022

FINA 2021 FINA vs Alexandra Sokolova

11 Apr 2022

Ms. Alexandra Sokolova is a Russian Open Water swimmer, affiliated with the Russian Swimming Federation until she retired in October 2015.

In January 2019 the World Anti-Doping Agency (WADA) recovered the internal database of the Moscow Laboratory (LIMS). Following investigation of allegations of organized doping practices, and in particular of the LIMS, WADA provided international federations with investigation reports on the athletes implicated in these organized doping practices.

In May 2021 the International Swimming Federation (FINA) opened an investigation into the Athlete after WADA had provided evidence that the Athlete had committed an anti-doping rule violation in 2013.

Hereafter in August 2021 FINA reported an anti-doping rule violation against the Athlete for the use of the prohibited substance Furosemide in 2013. After notification a provisional suspension was ordered. In August 2021 the Athlete denied the charges and then she failed to respond to any of the FINA communications.

FINA contended that in November 2013 the Athlete's sample tested positive for the prohibited substance Furosemide while she was part of a sophisticated doping scheme. The Moscow Laboratory did not report an Adverse Analytical Finding, instead the sample was falsely recorded as 'negative' in ADAMS by the Moscow Laboratory following the issuance of a "Save" directive.

In view of the WADA evidence the FINA Doping Panel finds that had been established that the Athlete had used the substance Furosemide in 2013. De Panel considers that there are aggravating circumstances in this case and deems that the Athlete failed to provide any explanations, nor grounds for a reduced sanction.

Therefore the FINA Doping Panel decides on 11 February 2022 to impose a 4 year period of ineligibility on the Athlete, starting on the date of the provisional suspension, i.e. on 25 August 2021. Further the Athlete's competitive results shall be disqualified from 23 November 2013.

ITF 2021 ITF vs Elsa Wan

8 Apr 2022

In November 2021 the International Tennis Federation (ITF) has reported an anti-doping rule violation against the Malaysian tennis player Elsa Wan after her A and B samples tested positive for the prohibited substance Pseudoephedrine.

After notification the Athlete gave a prompt admission, waived her right for a hearing and accepted the decision rendered by the ITF.

The Athlete denied the intentional use of the substance and explained with medical evidence that she suffered from an allergy and had used Nurofen Cold & Flu tablets. This product contained Pseudoephedrine and was purchased over-the-counter in a pharmacy. She had used the product the morning prior to the competion and had mentioned this product on the Doping Control Form.

The Athlete (17) asserted that she was unaware that Nurofen contained Pseudoephedrine and only had used it as treatment for her allergy. She had limited international competition experience and had not yet received any anti-doping education, nor her small support network.

Based on the evidence the ITF accepts that the Athlete had demonstrated that the violation was not intentional and how the substance had entered her system. The ITF considers the Athlete's conduct in this case and deems that she acted with No Significant Fault or Negligence. Finally the ITF regards that there had been delays in the proceeding not attributed to the Athlete.

Therefore the ITF decides on 8 April 2022 to impose an 18 month period of ineligibility on the Athlete, starting on 9 March 2022.

Joint-statement by the AIU of World Athletics and WADA in relation to the case of Italian race walker Alex Schwazer

7 Apr 2022

Joint-statement by the Athletics Integrity Unit of World Athletics and the World Anti-Doping Agency in relation to the case of Italian race walker Alex Schwazer / World Athletics; World Anti-Doping Agency (WADA). - 2021

Related cases:

  • CAS 2016_A_4707 Alex Schwazer vs IAAF, NADO Italia, FIDAL & WADA
    January 30, 2017
  • IOC 2012 IOC vs Alex Schwazer (id:1245;
    August 10, 2012


The World Anti-Doping Agency (WADA) notes the results of additional investigations into the case of Italian race walker, Alex Schwazer, the results of which confirm that the athlete’s sample collected on 1 January 2016 by World Athletics was not subject to any form of manipulation.

A decision of 18 February 2021, by investigating judge, Walter Pelino, from the Bolzano region of Italy, concluded that Mr. Schwazer’s sample was likely to have been manipulated. This was based on the contention that the concentration of DNA in the sample was too elevated to be physically possible and therefore that the sample must have been manipulated.

Upon WADA’s request, anti-doping scientist Professor Martial Saugy from the University of Lausanne, Switzerland has reviewed the manipulation scenario described in the decision of Judge Pelino. Professor Saugy’s report, which has now been published, establishes that the manipulation scenario devised by Judge Pelino is wholly implausible and that there is no analytical evidence of it.

In addition, since WADA’s statement in April 2021, the Athletics Integrity Unit (AIU), which since 2017 oversees anti-doping on behalf of World Athletics, commissioned the Forensic Genetics Unit laboratory in Lausanne (which has an ISO-accreditation for DNA analysis) to conduct a blind study involving the analysis of the urinary DNA concentrations of 100 samples* from male endurance athletes. The results demonstrate conclusively that the DNA concentration measured in Mr. Schwazer’s sample is within the normal physiological range. Indeed, much higher values were observed, even after years of storage, and approximately 20% of the samples studied had DNA concentrations greater than that detected in Mr. Schwazer’s sample. The highest concentration, which came from a sample that had been stored for three years before DNA analysis, was nearly 10 times higher than the highest concentration measured in Mr. Schwazer’s sample. Therefore, the whole basis for the manipulation scenario (i.e. that the DNA levels were not physically possible) is wrong.

In light of the new reports, WADA and the AIU have published a detailed joint-statement explaining why the manipulation theory does not stand up to scrutiny.

*These consisted of 85 separate samples. Additionally, in 15 cases, both the A and B samples were analyzed.

ISR 2021 KNKF Decision Disciplinary Committee 2021005 T

6 Apr 2022

In August 2021 the Dutch Royal Strength Sport and Fitness Federation (KNKF) has reported an anti-doping rule violation against the Person after his sample tested positive for the prohibited substance Drostanolone.

After notification the Person failed to file a statement in his defence, nor did he request to be heard for the ISR-NBB Disciplinary Committee. Accordingly the Committee renders a decision without a hearing based on the Parties' written submissions.

The Disciplinary Committee finds that the presence of a prohibited substance has been established in the Person's sample and accordingly that he committed an anti-doping rule violation.

The Committee holds that Person failed to respond and consequently refrained to explain how the substance entered his system. Neither did he establish that the violation was not intentional, nor grounds for a reduced sanction.

Therefore the ISR-KNKF Disciplinary Committee decides on 6 April 2022 to impose a 4 year period of ineligibility on the Person, starting on the date of the provisional suspension, i.e. 9 August 2021.

Fees and expenses for this committee shall be borne by the Person.

Category
  • Legal Source
  • Education
  • Science
  • Statistics
  • History
Country & language
  • Country
  • Language
Other filters
  • ADRV
  • Legal Terms
  • Sport/IFs
  • Other organisations
  • Laboratories
  • Analytical aspects
  • Doping classes
  • Substances
  • Medical terms
  • Various
  • Version
  • Document category
  • Document type
Publication period
Origin